General Updates

NITCO/SE/2026-27/23 July 23, 2026 Corporate Service Department The Listing Department BSE Limited National Stock Exchange of India Limited Jeejeebhoy Towers Exchange Plaza, Bandra Kurla Complex, Bandra Dalal Street, (E), Mumbai – 400 001 Mumbai – 400 051 Script code: 532722 Script code: NITCO Dear Sir/Madam, Sub: Intimation under Regulation 30 of SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015 – Allotment of equity shares upon conversion of share warrants. We wish to inform you that, pursuant to the approval of the shareholders of the Company accorded at the Extra-Ordinary General Meeting held on November 15, 2024, and pursuant to the in-principle approvals granted by BSE Limited vide Ref. No. LOD/PREF/HC/FIP/1696/2024-25 dated January 15, 2025 and the National Stock Exchange of India Limited vide Ref. No. NSE/LIST/44909 dated January 16, 2025, the Company had issued and allotted 2,34,10,000 convertible warrants to a promoter of the Company on January 27, 2025, by way of a preferential allotment. The issue price was Rs. 92.25 per warrant, out of which 25% of the issue price per warrant was received as the initial subscription amount at the time of allotment of the warrants. Out of the said warrants, 1,14,00,000 warrants were converted and alloted into an equivalent number of equity shares on March 23, 2026, upon receipt of the balance 75% of the issue price, in accordance with the terms and conditions of the issue. Further in accordance with Regulation 30 read with Schedule III of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015, the Board of Directors of the Company vide Circular Resolution dated July 23, 2026, approved the allotment of 65,04,065 (Sixty Five Lakhs Four Thousand and Sixty Five) equity shares of face value of Rs. 10/- each at a premium of Rs. 82.25/- per share to Mr. Vivek Prannath Talwar, Promoter of the Company, pursuant to the exercise and conversion of 65,04,065 convertible warrants out of balance 1,20,10,000 nos. of share warrants, upon receipt of the balance subscription amount i.e. 75% of the issue price from the allottee. Registered Office: NITCO Limited, 3/A, Recondo Compound, Sudam Kalu Ahire Marg, Glaxo, Worli Colony, Mumbai, Maharashtra, India, 400 030. Tel.: 91-22-25772800|25772790. CIN: L26920MH1966PLC016547. Email: investorgrievances@nitco.in Website: www. nitco.in As per Securities and Exchange Board of India (Issue of Capital and Disclosure Requirements) Regulations 2018, (referred as “SEBI ICDR”) the allottee can convert the balance warrants by July 26, 2026 (18 months from the date of allotment). The details required pursuant to Regulation 30 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015, read with SEBI Master Circular No. HO/49/14/14(7)2025-CFD-POD2/I/3762/2026 dated January 30, 2026, are enclosed as Annexure – A to this letter. Kindly take the above information on your record. Yours faithfully, For NITCO Limited Vivek Talwar Chairman & Managing Director DIN: 00043180 Encl.: As above Registered Office: NITCO Limited, 3/A, Recondo Compound, Sudam Kalu Ahire Marg, Glaxo, Worli Colony, Mumbai, Maharashtra, India, 400 030. Tel.: 91-22-25772800|25772790. CIN: L26920MH1966PLC016547. Email: investorgrievances@nitco.in Website: www. nitco.in ANNEXURE A The details as required to be disclosed under Regulation 30 of the SEBI Listing Regulations read with SEBI Master Circular No. HO/49/14/14(7)2025-CFD- POD2/I/3762/2026 dated January 30, 2026: Issue of Securities on Preferential basis Type of securities Fully paid equity shares upon conversion of share warrants Allotted Type of issuance Preferential Issue of Equity Shares upon conversion of warrants in accordance with the Chapter V of SEBI ICDR and other applicable laws. Total number of 65,04,065 (Sixty Five Lakh Four Thousand and Sixty Five) Equity securities allotted or Shares of face value of Rs. 10/- (Rupees Ten only) at a premium of the total amount for Rs. 82.25/- per share. which the securities are issued Names of the Allottee As per Annexure I Number of Allottee 1 (One) Issue of price Rs. 92.25/- per share, not being lower than the price to be determined in accordance with the SEBI ICDR In case of convertibles: An amount equivalent to 25% of the Warrant Issue Price has been intimation of received at the time of subscription and allotment of each Warrant conversion of securities and the balance 75% amount of the warrant issue price has been or on lapse of the received at the time of exercise of option of conversion of warrants tenure of the in to equity shares by the allottee to whom the warrants have been instrument allotted. Post allotment of 65,04,065 (Sixty Five Lakh Four Thousand and Sixty Five) number securities - outcome of of Equity Shares allotted shall rank pari-passu with existing equity the subscription, issue shares of the Company in all respects. price / allotted price (in case of convertibles) The Pre and Post Shareholding is provided in Annexure II Lock-In The Equity Shares/ Warrants/ Resulting Equity Shares shall be subject to ‘lock-in’ as prescribed under the applicable provisions of the Securities and Exchange Board of India (Issue of Capital and Disclosure Requirements) Regulations 2018. Registered Office: NITCO Limited, 3/A, Recondo Compound, Sudam Kalu Ahire Marg, Glaxo, Worli Colony, Mumbai, Maharashtra, India, 400 030. Tel.: 91-22-25772800|25772790. CIN: L26920MH1966PLC016547. Email: investorgrievances@nitco.in Website: www. nitco.in Annexure I Details of Allottee: Sr. Name of allottees No. of No. of Amount No. of warrants No. warrants Equity received being pending for applied for Shares 75% of the conversion conversion allotted issue price per warrant in 1 Mr. Vivek 1,20,10,000 65,04,065 45,00,00,000 55,05,935 Prannath Talwar (Promoter, Chairman and Managing Director) Registered Office: NITCO Limited, 3/A, Recondo Compound, Sudam Kalu Ahire Marg, Glaxo, Worli Colony, Mumbai, Maharashtra, India, 400 030. Tel.: 91-22-25772800|25772790. CIN: L26920MH1966PLC016547. Email: investorgrievances@nitco.in Website: www. nitco.in Annexure II Post allotment of securities- outcome of the subscription: Sr. Name of the Pre-Issue Shareholding Post-Issue Shareholding No. Allottees No. of % of No. of Equity % of Equity shareholding Shares shareholding Shares 1. Mr. Vivek 2,12,23,669 8.82 2,77,27,734 11.53% Prannath Talwar (Promoter, (Chairman and Managing Director) Registered Office: NITCO Limited, 3/A, Recondo Compound, Sudam Kalu Ahire Marg, Glaxo, Worli Colony, Mumbai, Maharashtra, India, 400 030. Tel.: 91-22-25772800|25772790. CIN: L26920MH1966PLC016547. Email: investorgrievances@nitco.in Website: www. nitco.in